Status:
COMPLETED
Lactobacillus Reuteri DSM 17938 in Functional Constipation
Lead Sponsor:
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Conditions:
Functional Constipation
Eligibility:
All Genders
19-65 years
Phase:
PHASE4
Brief Summary
The diffusion of gastrointestinal (GI) chronic diseases is significantly increased during the last century in western countries. In the USA and Northern Europe, constipation is twofold the prevalence ...
Eligibility Criteria
Inclusion
- Fulfilment of the Rome Criteria III for functional constipation
- Availability of at least one GI imaging study during the last five years (colonoscopy, sigmoidoscopy, abdominal ultrasound, barium enema)
- Commitment to availability for the whole study period
Exclusion
- Major abdominal surgery
- Presence of any concomitant diseases such as organic GI diseases and/or lactose and gluten intolerance; medical or psychiatric illness
- Alarming symptoms (rectal bleeding, weight loss, etc)
- Family history of peptic ulcer, colorectal cancer, or IBD
- Abnormal laboratory data or thyroid function.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01244945
Start Date
January 1 2011
End Date
January 1 2014
Last Update
March 27 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Digestive Diseases IRCCS "S. de Bellis"
Castellana Grotte, Bari, Italy, 70013